• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
CAO Feng, MA Yunan. Thoughts on current chemistry, manufacturing & control(CMC)technical review requirement of chemical active pharmaceutical ingredients[J]. Journal of China Pharmaceutical University, 2014, 45(3): 274-280. DOI: 10.11665/j.issn.1000-5048.20140304
Citation: CAO Feng, MA Yunan. Thoughts on current chemistry, manufacturing & control(CMC)technical review requirement of chemical active pharmaceutical ingredients[J]. Journal of China Pharmaceutical University, 2014, 45(3): 274-280. DOI: 10.11665/j.issn.1000-5048.20140304

Thoughts on current chemistry, manufacturing & control(CMC)technical review requirement of chemical active pharmaceutical ingredients

More Information
  • This article reviews drug research and evaluation history in China in the last decades, which analyses current status of Chinese pharmaceutical industry and changes of chemical active pharmaceutical ingredient evaluation principles and technical requirement from Center for Drug Evaluation(CDE)of China Food and Drug Administration(CFDA). Key points during the research and development of active pharmaceutical ingredient are detailed analyzed in connection with the current drug evaluation status and issues should be paid attention during the drug research and development are introduced from synthesis process, control of starting material and intermediate, key steps and processing parameters, crystal form, batch, structural identification, research of quality, quality standard and stability and other perspectives. This article can be considered by persons for drug research and development in China.
  • [1]
    Chen Z.Progress of CMC technical requirements for registration of chemical drugs in China[J].Chin New Drugs J(中国新药杂志),2014,23(1):20-24.
    [2]
    China Food and Drug Administration.2012 China drug review annual report[J].Chin New Drugs J(中国新药杂志),2013,22(6):611-616.
    [3]
    Chen Z.Study on related substances and new drug application[J].Chin J Pharma(中国医药工业杂志),2010,4(11):872-876.
  • Related Articles

    [1]LIANG Jinlai, XU Wei, YIN Tingjie, HUO Meirong. Advances in the hypoxia-responsive antitumor drug nanocarriers and tumor hypoxia relieve[J]. Journal of China Pharmaceutical University, 2018, 49(3): 255-262. DOI: 10.11665/j.issn.1000-5048.20180301
    [2]GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
    [3]GAO Yahan, PING Qineng, ZONG Li. Preparation and antitumor activity of mitoxantrone conjugated D-α-tocopherylpolyethylene glycol 1000 succinate prodrug micelle[J]. Journal of China Pharmaceutical University, 2016, 47(3): 311-316. DOI: 10.11665/j.issn.1000-5048.20160311
    [4]LIU Yan, WANG Tingting, CHEN Li. Synthesis and antitumor activity of isosteviol derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(1): 48-53. DOI: 10.11665/j.issn.1000-5048.20160106
    [5]LIU Wenhu, CHANG Jinxia, ZHANG Jianwu. Synthesis and antitumor activities of novel coumarin derivatives containing chalcone moiety[J]. Journal of China Pharmaceutical University, 2014, 45(5): 522-528. DOI: 10.11665/j.issn.1000-5048.20140503
    [6]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [7]LI Linhu, CHEN Li, XIA Yufeng. Progress in the study of coumarin derivatives as antitumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(4): 374-379. DOI: 10.11665/j.issn.1000-5048.20130417
    [8]JIN Hui, LIU Lifeng, DENG Weiping, LIU Jianwen. Antitumor effects and molecular mechanisms of novel selective HDAC inhibitors in human cervix carcinoma HeLa cells[J]. Journal of China Pharmaceutical University, 2013, 44(4): 352-356. DOI: 10.11665/j.issn.1000-5048.20130413
    [9]Studies on the Difference in Content of an Antitumor Component 5F in Pteris semipinnata L.[J]. Journal of China Pharmaceutical University, 2002, (5): 48-50.
    [10]Antitumor Effect of Fu Fang Xiao Liu Wan[J]. Journal of China Pharmaceutical University, 1997, (1): 42-44.

Catalog

    Article views (1310) PDF downloads (3020) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return